Pharmacokinetics of the three radioiodinated dopamine D2 receptor ligands [123I]IBF, [123I]epidepride and [123I]2′-ISP in nonhuman primates

This publication has 22 references indexed in Scilit:

• Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor
  Nuclear Medicine and Biology, 1994
• Evaluation of the monoamine uptake site ligand [131I]methyl 3β-(4-Iodophenyl)-tropane-2β-carboxylate ([123I]β-CIT) in non-human primates: Pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI
  Nuclear Medicine and Biology, 1993
• Amphetamine‐stimulated dopamine release competes in vivo for [¹²³I]IBZM binding to the D2 receptor in nonhuman primates
  Synapse, 1992
• Preparation of [¹²³I]‐ and [¹²⁵I]epidepride: A dopamine D‐2 receptor antagonist radioligand
  Journal of Labelled Compounds and Radiopharmaceuticals, 1991
• Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders
  Journal of Cerebral Blood Flow & Metabolism, 1991
• NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors
  Psychopharmacology, 1991
• A new method to prepare no‐carrier‐added iodinated spirodecanone derivatives:1 application to dopaminergic and serotoninergic ligands
  Journal of Labelled Compounds and Radiopharmaceuticals, 1990
• Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions
  Neuroscience, 1989
• A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride
  Neuroscience, 1987
• Tardive dyskinesia: review and update
  American Journal of Psychiatry, 1980